Leadership

Angela has broad experience successfully supporting pharma and biotech clients across commercial, corporate development, and market access strategy engagements. In that context, Angela has worked across major therapeutic areas, with a recent focus on oncology, immunology, rare diseases, and neurology/neuropsychiatry. She has extensive experience in launch pricing and contracting strategy, paired with a deep understanding of the roles and influence of key market players (health systems, payers, distributors, etc.) and market dynamics (e.g., U.S. policy changes, drug reimbursement). In the project setting, Angela places significant importance on client service, feedback/mentorship, and developing clear, practical solutions to challenging business questions.

 

Angela leverages over 10 years of experience in the life sciences, including translational research at Yale University prior to joining Clearview. She earned her B.S. in Molecular, Cellular, and Developmental Biology from Yale University.